Indivior PLC (INDV) Income Statement

NASDAQ: INDVRevenue, profits, margins and EPS over 10 years.

INDV 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+4.3%
$1.24B
2025 · hover or tap a bar for each year
2016: $968.9M2017: $1.15B (+18.5%)2018: $959.9M (−16.4%)2019: $785.0M (−18.2%)2020: $647.0M (−17.6%)2021: $791.0M (+22.3%)2022: $901.0M (+13.9%)2023: $1.09B (+21.3%)2024: $1.19B (+8.7%)2025: $1.24B (+4.3%)
20162025
Gross profit+3.8%
$993.0M
2025 · hover or tap a bar for each year
2016: $858.1M2017: $1.03B (+19.5%)2018: $825.2M (−19.5%)2019: $645.0M (−21.8%)2020: $550.0M (−14.7%)2021: $664.0M (+20.7%)2022: $750.0M (+13.0%)2023: $919.0M (+22.5%)2024: $957.0M (+4.1%)2025: $993.0M (+3.8%)
20162025
Operating income+728.1%
$265.0M
2025 · hover or tap a bar for each year
2016: $337.9M2017: $423.3M (+25.3%)2018: $317.1M (−25.1%)2019: $178.0M (−43.9%)2020: −$156.0M (−187.6%)2021: $213.0M2022: −$81.0M (−138.0%)2023: −$156.0M2024: $32.0M2025: $265.0M (+728.1%)
20162025
Net income+10,400.0%
$210.0M
2025 · hover or tap a bar for each year
2016: $32.1M2017: $60.9M (+90.1%)2018: $262.7M (+331.1%)2019: $134.0M (−49.0%)2020: −$148.0M (−210.4%)2021: $205.0M2022: −$44.0M (−121.5%)2023: −$129.0M2024: $2.0M2025: $210.0M (+10,400.0%)
20162025
EPS (diluted)+112.1%
$2.46
2025 · hover or tap a bar for each year
2016: $1.742017: $0.38 (−78.2%)2018: $1.85 (+386.8%)2019: $0.86 (−53.5%)2020: −$1.05 (−222.1%)2021: $1.312022: −$0.44 (−133.6%)2023: $1.562024: $1.16 (−25.6%)2025: $2.46 (+112.1%)
20162025
Net profit margin+16.8 pts
16.9%
2025 · hover or tap a point for each year
2016: 3.3%2017: 5.3% (+2.0 pts)2018: 27.4% (+22.1 pts)2019: 17.1% (−10.3 pts)2020: −22.9% (−39.9 pts)2021: 25.9% (+48.8 pts)2022: −4.9% (−30.8 pts)2023: −11.8% (−6.9 pts)2024: 0.2% (+12.0 pts)2025: 16.9% (+16.8 pts)
20162025

INDV revenue and net income

RevenueNet incomeNet margin (right axis)

Where INDV's revenue goes

2025
Revenue
$1.24B100.0%
Cost of revenue
−$246.0M−19.9%
Gross profit
$993.0M80.1%
Research & development
−$97.0M−7.8%
Sales, general & admin
−$634.0M−51.2%
Operating income
$265.0M21.4%
Interest & other expense
−$26.0M−2.1%
Income taxes
−$29.0M−2.3%
Net income
$210.0M16.9%

Each bar shows an amount and its share of revenue. INDV kept 16.9% of revenue as net income.

INDV profit margins

GrossOperatingNet

INDV growth rates

to 2025
1 year3 years5 years10 years
Revenue+4.3%+11.2%+13.9%—
Gross profit+3.8%+9.8%+12.5%—
Operating income+728.1%———
Net income+10,400.0%———
EPS (diluted)+112.1%———

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

INDV quarterly EPS vs estimates

Reported EPSAnalyst estimate

Indivior beat the analyst EPS estimate in 7 of the last 8 quarters. Next report: October 29, 2026 (estimate $0.93).

INDV income statement

Indivior PLC annual income statement
2025202420232022202120202019201820172016
Revenue$1.24B$1.19B$1.09B$901.0M$791.0M$647.0M$785.0M$959.9M$1.15B$968.9M
Cost of revenue$246.0M$231.0M$174.0M$151.0M$127.0M$97.0M$140.0M$134.7M$122.9M$110.8M
Gross profit$993.0M$957.0M$919.0M$750.0M$664.0M$550.0M$645.0M$825.2M$1.03B$858.1M
Research & development$97.0M$107.0M$116.0M$74.0M$52.0M$40.0M$53.0M$64.0M$93.5M$109.0M
Sales, general & admin$634.0M$618.0M$569.0M$469.0M$239.0M$649.0M$395.0M———
Total operating expenses$728.0M$925.0M$1.07B$831.0M$451.0M$706.0M$467.0M$508.1M$601.9M$520.2M
Operating income$265.0M$32.0M−$156.0M−$81.0M$213.0M−$156.0M$178.0M$317.1M$423.3M$337.9M
Interest income$22.0M$23.0M$43.0M$19.0M$4.0M$9.0M$24.0M———
Interest expense$45.0M$41.0M$35.0M$29.0M$26.0M$24.0M$22.0M$31.0M$49.0M$51.0M
Income before taxes$239.0M$14.0M−$149.0M−$89.0M$190.0M−$173.0M$180.0M$265.5M$143.9M$89.7M
Income taxes$29.0M$11.0M−$20.0M−$44.0M−$15.0M−$25.0M$46.0M$2.9M$83.0M$57.7M
Net income$210.0M$2.0M−$129.0M−$44.0M$205.0M−$148.0M$134.0M$262.7M$60.9M$32.1M
EBITDA$304.0M$83.0M−$99.0M−$46.0M$238.0M−$123.0M$230.0M$310.4M$437.0M$149.3M
EPS (diluted)$2.46$1.16$1.56−$0.44$1.31−$1.05$0.86$1.85$0.38$1.74
Gross margin80.1%80.6%84.1%83.2%83.9%85.0%82.2%86.0%89.3%88.6%
Operating margin21.4%2.7%−14.3%−9.0%26.9%−24.1%22.7%33.0%36.9%34.9%
Net margin16.9%0.2%−11.8%−4.9%25.9%−22.9%17.1%27.4%5.3%3.3%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in INDV's financial statements (latest annual report filed February 26, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

INDV financial results

In fiscal year 2025 (ended December 31, 2025), Indivior reported revenue of $1.2 billion, up 4.3% from the year before. It had net income of $210.0 million (up 10,400.0%), a net profit margin of 16.9%. Diluted earnings per share came to $2.46. Over five years revenue grew at an average rate of 13.9% a year.

See the INDV stock overview for the latest quote and news, or the INDV chart for price history and technical indicators.

INDV income statement FAQ

What is Indivior's annual revenue?

Indivior reported total revenue of $1.2 billion for fiscal year 2025, which ended on December 31, 2025. That was up 4.3% from $1.2 billion the previous year.

Is Indivior profitable?

Yes. Indivior reported net income of $210.0 million in fiscal 2025, a net profit margin of 16.9%; its operating margin was 21.4%.

What is Indivior's gross margin?

Indivior's gross margin was 80.1% in fiscal 2025: for every $100 of revenue, Indivior kept $80 after the direct cost of its products and services.

How much does Indivior spend on research and development?

Indivior spent $97.0 million on research and development in fiscal 2025, 7.8% of revenue.

How fast is Indivior growing?

Revenue grew 13.9% a year on average over the last five fiscal years, from $647.0 million to $1.2 billion.

What are Indivior's earnings per share?

Indivior earned $2.46 per diluted share in fiscal 2025, compared with $1.16 a year earlier.

When will Indivior report its next earnings?

Indivior is expected to report results for the quarter ending September 30, 2026 on October 29, 2026.

When does Indivior's fiscal year end?

Indivior's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 26, 2026.

Drug Manufacturers - Specialty & Generic income statements